通过代谢途径评估前列腺癌的预后
1Department of Clinical Laboratory Medicine, Yuquan Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 100040, China. suqiang@buaa.edu.cn.
Discover oncology
|October 3, 2025
概括
这项研究开发了一种基于新陈代谢的预后模型,使用五种基因特征来预测前列腺癌复发. 该模型有效地识别了患有生化复发风险的患者,有助于预后.
科学领域:
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
- 生物信息学是一种生物信息学.
背景情况:
- 前列腺癌 (PCa) 的发病因子受到细胞代谢的显著影响.
- 识别与代谢相关的基因对于预测PCa预后至关重要.
研究的目的:
- 探索与代谢相关的基因,以预测PCa的预后.
- 构建和验证PCa的基于代谢的预后模型.
主要方法:
- 利用来自TCGA和GEO数据库的RNA数据和临床参数.
- 基于五种与代谢相关的基因特征开发了一个风险评分 (RS).
- 为预测生化无复发生存率 (BCRFS) 构建并评估了一个名图.
主要成果:
- 从860个与代谢相关的基因中选择了5个基因特征.
- RS在生化复发 (BCR) 方面表现出高的预后能力.
- 诺莫图有效地预测了BCRFS;GO分析将代谢基因与DNA损伤联系起来;KEGG分析突出了硫代谢途径.
结论:
- 建立了一个强大的,基于代谢的前列腺癌预后模型.
- 该模型显示了在PCa预后中临床应用的潜力.
更多相关视频
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
12.7K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.1K
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
